Business Standard

NTAGI members agree on reducing Covid booster dose gap; discuss monkeypox

NTAGI members agreed on reducing the gap between the second and precaution doses of Covid-19 vaccines from the current nine to six months, official sources said

Topics
Coronavirus | Coronavirus Vaccine | indian government

Press Trust of India  |  New Delhi 

covid, covid vaccine, coronavirus

Members of the government advisory panel NTAGI on Thursday agreed on reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said.

A recommendation for it will be made to the Ministry soon, they said.

The NTAGI's Standing Technical Sub-Committee (STSC), which met on Thursday, also reviewed the findings of a study by the Christian Medical College (CMC) in Vellore on the feasibility of allowing as precaution dose a Covid vaccine different from the one used for primary vaccination.

The panel members found a lack of uniformity in results upon mixing of jabs for booster shots and stated that no recommendation for it can be made as of now. The CMC study was on Covishield and Covaxin.

The threat of monkeypox and the requirement of vaccination were also discussed in the meeting, the sources said.

"However, the members were of the view that a strong surveillance is what is required as of now. No case of monkeypox has been detected in the country till now," one of the sources told PTI.

The panel also reviewed data on Covaxin and Corbevax vaccines for the 6-12 age group.

"The members opined that data of Covid burden and mortality among children is not robust enough to take any decision to begin vaccination of those below 12 years," the source stated.

India's drug regulator in April this year had granted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in the age group of six to 12 years.

The STSC members were learnt to have also agreed on administration of an additional third dose for renal transplant patients before the precaution dose.

"In the meeting today, members also agreed on reducing the gap between the second and the precaution doses of COVID-19 vaccines from the current nine months to six months," the source told PTI.

Currently, all those above the age of 18 who have completed nine months after the administration of the second dose are eligible for the precaution dose.

The Union government last month allowed citizens and students travelling overseas to get the shot before the stipulated nine-month waiting period as required by the guidelines of the destination country.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, June 17 2022. 06:33 IST
RECOMMENDED FOR YOU
.